Atara Biotherapeutics, Inc. - Common Stock (ATRA)

CUSIP: 046513107

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / Common Stock
Shares outstanding
8,165,808
Total 13F shares
21,590,915
Share change
+1,960,575
Total reported value
$486,014,073
Price per share
$22.51
Number of holders
70
Value change
+$46,726,583
Number of buys
50
Number of sells
14

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q2 2016

As of 30 Jun 2016, Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,590,915 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, Redmile Group, LLC, Arrowpoint Asset Management, LLC, UBS ASSET MANAGEMENT AMERICAS INC, BRIDGER MANAGEMENT, LLC, EAGLE ASSET MANAGEMENT INC, BlackRock Fund Advisors, VANGUARD GROUP INC, and Neuberger Berman Group LLC. This page lists 70 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2016 vs Q1 2016 Across Filers

Q1 2016 holders
69
Q2 2016 holders
70
Holder diff
1
Investor Q1 2016 Shares Q2 2016 Shares Share Diff Share Chg % Q1 2016 Value $ Q2 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.